Abstract Ultrasonographic, blinded assessment was made of the extent of hepatic steatosis in 55 children with severe malnutrition: undernutrition (n=6), marasmus (n= 18), marasmickwashiorkor (n= 17), and kwashiorkor (n= 14). The children were examined on admission, in early recovery (considered as baseline), and again at discharge. Eleven healthy control children and eight of the previously malnourished children were studied as comparison groups.
Kwashiorkor, or oedematous childhood malnutrition, was described by Cecily Williams in 1935. Her description included the statement: 'Post-mortem, the only constant finding is an extreme fatty infiltration of the liver'.1 The precise pathogenesis of this accumulation of fat in the liver remains unexplained; however, the severity of the pathological change is beyond doubt. The median fat content of liver biopsy samples taken from severely malnourished Jamaican children was 30-35%, and it appro- Hepatic steatosis is usually held to be a clinical feature only ofoedematous malnutrition5 and standard textbooks categorically state that 'fatty liver does not occur in marasmus'. 6 Waterlow, however, mentions one marasmic child with a fat content of 35% liver wet weight,2 and other authors have reported similar cases.7-9 It is unclear if these are isolated cases or whether hepatic steatosis frequently occurs in marasmus and undernutrition-the nonoedematous forms of childhood malnutrition.
Previous studies have used chemical analysis or histological grading of liver biopsy tissue to assess liver steatosis. These series were, of necessity, limited to patients with definite indications for biopsy and therefore excluded both children with very severe illness and those with mild forms of the disease; further, in very few patients has more than a single assessment been made.
Recently ultrasonography has been validated and used to assess liver fatty infiltration in adults; the hepatic steatosis can be demonstrated with high sensitivity (94%) and specificity (84%). '10 The aim of the present study was to examine the extent of hepatic steatosis, longitudinally, in an unselected series of severely malnourished Jamaican children.
Subjects and methods

STUDY CHILDREN
The study group 
Discharge weight for height (Z) +0 1 (0-6) -0-6 (0-7) +0 1 (0-5) +0 1 (0 6) Time admission to baseline study (days) 11 (3) 8 (3) 9 (2) 13 (6) Time baseline to discharge study (days) 29 (10) 34 (10) 26 (11) 26 (7) Z=SD scores from the NCHS standard height of a child of the same age and weight for a child of the same height. Children without oedema (undernutrition and marasmus) were older than the oedematous (marasmic-kwashiorkor and kwashiorkor) children (p<0 05), and a higher proportion were male (table 1). The undernourished children were not as stunted as the marasmic children: however, they were just as wasted (deficit in weight-for-height); this indicates that the two non-oedematous groups had had similar recent nutritional insults. The times between the three studies were not different among the groups.
All three assessments were made on 51 of the 55 children: one child was considered too ill for ultrasonography to be performed at admission; two children died (one with marasmickwashiorkor after the admission, the other, with kwashiorkor, after the admission and baseline study); one child was inadvertently discharged before the final ultrasound. HEPATIC 
STEATOSIS
The results are shown in fig 1. Control subjects, with one exception, had a steatosis grade of 0 or 1. The exception was a 16 month old boy, resident in the children's home, who was assessed as having grade 2 steatosis. Clinical examination of the child and conventional liver function tests were normal. The previously malnourished children, studied at follow up also had either grade 0 or grade 1 steatosis.
At admission 51 of the 54 children had evidence of fat in their livers: the one child who was too ill for assessment, at this time, had grade 5 steatosis at baseline. For each of the diagnoses, at both admission and baseline, the extent of hepatic steatosis was significantly greater than the controls (fig 1) (p<001) . The extent of hepatic steatosis was different within the four groups, at each stage of the study (p<002).
The grade was greater in children with oedematous malnutrition than non-oedematous and greater in those with kwashiorkor than those with marasmic-kwashiokor (p<0 0001). Children without oedema, however, had appreciable hepatic steatosis (fig 1) . Eight of 17 children with marasmus and three of six with undernutrition had an hepatic ultrasound severity score -2 both at admission and at baseline. Figure 2 shows the distance weighted least 8-1 (1 3) [8] [9] (2-1) 9 5 (1-8) Baseline 8-2 (0 9) [7] [8] (1 0) ( 1 7) 9-2 (1-1) Discharge 9-2 (1-2) (1-3) (1 1) (1-0)
RECOVERY OF FATTY LIVER
'Liver size measured as liver span (cm)x 100/height of child (cm). The extent of liver fat in the present population was not measured directly; however, the cases were similar to those studied by Waterlow in whom the median amount of fat was about 30-35% of total liver wet weight.2 The distribution of his cases in % fat classes and of our cases into grades was also similar. Thus, we would anticipate our grade 4 to correspond to Waterlow's 30-40% fat and our grade 5 to more than 40% fat. Although this is an assumed correspondence between the grades and chemical composition, the extent of liver fat in these children is likely to be much greater than in the adult population in which the method was quantitatively validated. Nevertheless, our assessment was made in a masked fashion by an experienced ultrasonographer who had no knowledge of the subjects.
The study confirms the frequency of fatty liver in children with oedematous malnutrition, although there are a few oedematous children without appreciable fatty liver (3-6%). However, our results also show that fatty liver is usually present in marasmus and undernutrition-nonoedematous forms of malnutrition. In the Wellcome classification of malnutrition,"I nutritional oedema is equated with kwashiorkor; however, fatty liver is part of the clinical syndrome of kwashiorkor.' The finding, that fatty liver is frequently present in marasmus, blurs the differences between the Wellcome definitions of kwashiorkor and marasmus. Clearly, the Wellcome classification is useful, among other things, for studies of the pathogenesis of oedema whereas it is misleading if used for studies of the pathogenesis of fatty liver.
The rate of clearance of the fat in the liver was remarkably slow, with up to one quarter of children not apparently metabolising any of the fat in their livers during recovery. Our figure of 1-4%/day is in broad agreement with Waterlow's two estimates of 5-5%/day and 0-9%/day, using different assumptions. If a 7 kg child has a 400 g liver, with 35% wet weight as fat (20 g hepatic fat/kg) and he mobilises 1-4%/day then only 10-6 kJ/kg/day (2 5 kcal) is coming from hepatic fat. Even if the higher of Waterlow's estmnates is used, less than 40 kJ/kg/day is supplied from hepatic fat. This is a relatively tiny fraction of the energy consumption of these children, who become markedly hypermetabolic during their period of rapid weight gain.23 Their dietary energy supply is closely related to their rate of recovery24 25: the children frequently consume 800 kJ/kg/day with 60% of this energy coming from fat; thus, children may oxidise 13 g fat/kg/day. 25 Five girls and two boys aged between 3 and 14 years were treated. All had severe asthma and were receiving regular oral prednisone in doses ranging from 30 mg on alternate days to 60 mg daily in addition to inhaled treatment with salbutamol, sodium cromoglycate, and beclomethasone, and oral theophylline. Two of the seven patients had frequent emergency department visits and hospital admissions but one of them was thought to be noncompliant with treatment. Methotrexate was given in a starting dose of 2 5 mg once a week and the dose was increased by 2 5 mg every four weeks to a maximum of 17-5 mg in two patients, 12 5 mg in three, and 7 5 mg in one. One patient was unable to tolerate the drug and had only two doses.
No patient showed any improvement in the asthma in the first three months of methotrexate treatment but eventually three patients came off steroids and two were able to take a much reduced dose. Data are provided about spirometric measurements before and during treatment but they are difficult to interpret because we are not told when the values given were obtained and whether they represent an average over a period of time or single recordings. One patient showed no response after treatment for six months. One 9 year old had all her treatment stopped by her family when her asthma improved after four months of methotrexate. Two children apparently deteriorated and improved again when the course of methotrexate was interrupted and restarted.
The authors try very hard, in my opinion too hard, to make a case for methotrexate. They emphasise the toxicity of steroids in comparison with methotrexate in a quite arbitrary fashion and their assessment of their results does not seem to be totally unbiased. For instance they claim that methotrexate led to fewer emergency visits and admissions to hospital when it is quite clear from their data that there was no significant effect in these respects. They point out in high falutin terms that the study was uncontrolled and therefore the value of the drug remains uncertain but they encourage doctors to try the drug on a 'give it and see' basis. There is serious concern about the potential toxicity of methotrexate with pneumonitis, pulmonary fibrosis, and hepatic fibrosis being the main worries. In the present state of knowledge it seems to me that to encourage anything other than a strictly monitored controlled trial would be hard to justify. As far as treating individual patients is concerned, if there is a flag indicating 'proceed with extreme caution' it would seem appropriate to wave it vigorously at this point.
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